Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT06939361

Tube Size Randomized Trial During Emergency Tracheal Intubation

The BREATHE trial is a parallel-group, pragmatic, randomized clinical trial comparing the effectiveness of smaller versus larger endotracheal tubes for mechanical ventilation of critically ill adults at 7 geographically diverse centers. A total of 3,180 critically ill adults undergoing tracheal intubation in the ED or ICU will be enrolled. Enrolled patients will be randomly assigned in a 1:1 ratio to receive either a smaller endotracheal tube (a 6.5 mm endotracheal tube for patients shorter than 64 inches and a 7.0 mm endotracheal for patients at least 64 inches) or a larger endotracheal tube (a 7.5 mm endotracheal tube for patients shorter than 64 inches and a 8.0 mm endotracheal for patients at least 64 inches). Patients will be followed for 6 months after enrollment. The primary outcome will be breathlessness at 6 months. The secondary outcomes will be voice quality and swallowing at 6 months.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Alabama Hospital, Birmingham, Alabama, United States

Loading trial locations.

About this study

Each year, approximately 1% of the US population (2-3 million adults) experiences critical illness requiring placement of an endotracheal tube. While 60-80% of patients survive, more than half of survivors experience long-term problems with breathing, speaking, or swallowing. Identifying approaches that prevent long-term complications of critical illness is an urgent priority.

For every patient undergoing emergency tracheal intubation, clinicians select the size of endotracheal tube. The size of the endotracheal tube refers to the inner diameter of the tube. Smaller endotracheal tubes commonly used in adults have a diameter of 6.5 mm to 7.0 mm. Larger endotracheal tubes commonly used in adults have a diameter of 7.5 mm to 8.0 mm.

In current clinical care, some clinicians routinely use smaller endotracheal tubes while others routinely use larger endotracheal tubes. In a cohort of 2,652 patients enrolled in three recent trials conducted by our Pragmatic Critical Care Research Group (PCCRG), clinicians used a smaller endotracheal tube for 44.5% of patients and a larger endotracheal tube for 55.5%. While height and sex are the primary determinants of the diameter of a patient's trachea, these variables explain only 12% of the variation in the size of endotracheal tube clinicians use in current clinical care. This suggests that selection of endotracheal tube size in clinical practice is not "personalized" to the characteristics of the patient, but instead varies based on factors like the specialty of the clinician, the practice patterns of the hospital, and the region of the country.

Whether using a smaller vs larger endotracheal tube affects any patient outcome is unknown. Some experts have hypothesized that use of larger endotracheal tubes may cause acute injury to the larynx, which for some patients could progress to permanent scarring, impairing breathing, speaking, and swallowing. Thus, some experts currently recommend using smaller endotracheal tubes. Other experts hypothesize that the use of larger endotracheal tubes may reduce resistance to gas flow, reducing patients' work of breathing during spontaneous breathing trials, and making it easier to pass suction catheters, obtain diagnostic samples, and clear secretions. Such experts, therefore, currently recommend using larger endotracheal tubes in hopes that doing so might shorten the duration of invasive mechanical ventilation or even decrease the risk of death during critical illness. No randomized trials have ever compared smaller versus larger endotracheal tube sizes among critically ill adults. Only one observational study has evaluated the effect of endotracheal tube size on outcomes of critical illness. It suggested that smaller endotracheal tubes had no effect on survival to hospital discharge but could not exclude the possibility that endotracheal tube size might affect the duration of invasive mechanical ventilation. The study prompted published responses highlighting the lack of long-term outcomes and the biases inherent to observational studies, noting that the effects of smaller versus larger endotracheal tubes could only be proven with a randomized trial.

Because millions of critically ill adults receive either a smaller or larger endotracheal tube during tracheal intubation in an ED or ICU each year, and no prior randomized trial has evaluated the effect of endotracheal tube size on long-term outcomes (breathing, speaking, and swallowing) or short-term outcomes (duration of invasive mechanical ventilation and survival), a multicenter randomized trial is needed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient is undergoing orotracheal intubation with an endotracheal tube in a participating unit
  • Planned operator is a clinician expected to routinely perform tracheal intubation in the participating unit

Exclusion criteria

  • Patient is known to be less than 18 years old
  • Patient is known to be pregnant
  • Patient is known to be a prisoner
  • Use of an endotracheal tube with subglottic suction is planned
  • Operator has determined that use of a smaller endotracheal tube or a larger endotracheal tube is required or contraindicated for the optimal care of the patient
  • Immediate need for tracheal intubation precludes safe performance of study procedures

Treatment and study plan

Smaller endotracheal tube

Other
  • Inner diameter 7.0 mm (for patients with a height ≥ 64 inches)
  • Inner diameter 6.5 mm (for patients with a height < 64 inches)

Larger endotracheal tube

Other
  • Inner diameter 8.0 mm (for patients with a height ≥ 64 inches)
  • Inner diameter 7.5 mm (for patients with a height < 64 inches)

Primary outcomes

  1. Breathlessness at 6 months after intubation

    Time frame: At 6 months after enrollment

    Primary Effectiveness Outcome: Breathlessness will be measured using the Clinical COPD Questionnaire (CCQ). Scores range from 0 (least severe) to 6 (most severe).

Secondary outcomes

  1. Ventilator-free days in the first 28 days

    Time frame: From enrollment to 28 days after enrollment

    Primary Safety Outcome: The number of days alive and free of invasive mechanical ventilation from enrollment to 28 days after enrollment.

  2. All-cause, in-hospital mortality by 28 days

    Time frame: From enrollment to 28 days after enrollment

    Primary Safety Outcome: Death from any cause from enrollment to 28 days after enrollment, censored at hospital discharge.

  3. Voice impairment at 6 months after intubation

    Time frame: At 6 months after enrollment

    Secondary Effectiveness Outcome: voice impairment at 6 months after enrollment as measured using the Voice Handicap Index (VHI) survey. Scores range from 0 (least severe) to 40 (most severe).

  4. Swallowing impairment at 6 months after intubation

    Time frame: At 6 months after enrollment

    Secondary Effectiveness Outcome: Swallowing impairment at 6 months after enrollmnet as measured using the EAT-10 survey. Scores range from 0 (least severe) to 40 (most severe).

Other outcomes

  1. Successful intubation on the first attempt.

    Time frame: Duration of placement of the endotracheal tube, an average duration of two minutes

    Successful intubation on the first attempt is defined as placement of an endotracheal tube in the trachea with a single insertion of a laryngoscope blade into the mouth and EITHER a single insertion of an endotracheal tube into the mouth OR a single insertion of a bougie into the mouth followed by a single insertion of an endotracheal tube over the bougie into the mouth.

  2. Number of laryngoscopy attempts

    Time frame: Duration of placement of the endotracheal tube, an average duration of two minutes

  3. Number of attempts to cannulate the trachea with a bougie

    Time frame: Duration of placement of the endotracheal tube, an average duration of two minutes

  4. Number of attempts to cannulate the trachea with an endotracheal tube

    Time frame: Duration of placement of the endotracheal tube, an average duration of two minutes

  5. Time from initiation of laryngoscopy to intubation of the trachea

    Time frame: Duration of placement of the endotracheal tube, an average of 60 seconds

    Time from initiation of laryngoscopy to intubation of the trachea in seconds

  6. Severe hypoxemia

    Time frame: During procedure (between induction and 2 minutes after tracheal intubation).

    Lowest oxygen saturation <80%

  7. Agitation

    Time frame: From intubation to 7 days after enrollment

    As measured by the occurrence of a Richmond Agitation-Sedation Scale (RASS) ≥ +2

  8. Delirium

    Time frame: From intubation to 7 days after enrollment

    As measured by the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU)

  9. Tracheostomy

    Time frame: From intubation to 28 days after enrollment

    Occurence of a tracheostomy procedure.

  10. Percutaneous gastrostomy tube placement

    Time frame: From intubation to 28 days after enrollment

    Occurence of a gastrostomy tube placement.

  11. Endotracheal tube exchange

    Time frame: From intubation to 28 days after enrollment

    Exchange of the endotracheal tube for any reason during the index course of invasive mechanical ventilation

  12. Reintubation within 72 hours of extubation from the index course of invasive mechanical ventilation

    Time frame: Within 72 hours of extubation

    Any placement of an endotracheal tube in the trachea (e.g., endotracheal tube, tracheostomy) between extubation from the index course of invasive mechanical ventilation and 72 hours following extubation, excluding reintubations for the purpose of a procedure that lasts <24 hours.

  13. Ventilator associated pneumonia during the index course of invasive mechanical ventilation

    Time frame: From intubation to 28 days after enrollment

    New lung infiltrate plus clinical evidence that the infiltrate is of an infectious origin, which include the new onset of fever, purulent sputum, leukocytosis, and decline in oxygenation, beginning > 48 hours after enrollment.

  14. ICU-free days in the 28 days after enrollment

    Time frame: From intubation to 28 days after enrollment

  15. Hospital-free days in the 28 days after enrollment

    Time frame: From intubation to 28 days after enrollment

  16. All-location mortality by 28 days

    Time frame: At 28 days after enrollment

  17. All-cause, all-location mortality by 6 months

    Time frame: At 6 months after enrollment

  18. Prescence of a tracheostomy at 6 months

    Time frame: At 6 months after enrollment

  19. Cough at 6 months

    Time frame: At 6 months after enrollment

    As measured by the Cough Severity Index. Scores range from 0 (no cough) to 40 (severe cough).

  20. Throat pain at 6 months

    Time frame: At 6 months after enrollment

    As measured by the Numeric Rating Scale. Scores range from 0 (no pain) to 10 (most severe pain).

  21. Voice quality at 6 months

    Time frame: At 6 months after enrollment

    As measured by the Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V). Scores range from 0 (mildly deviant) to 100 (severely deviant).

  22. Quality of life at 6 months

    Time frame: At 6 months after enrollment

    As measured by the EQ-5D-5L health-related quality of life measure. Scores range from 0 (worst health) to 100 (best health).

  23. Anxiety at 6 months

    Time frame: At 6 months after enrollment

    As measured by the General Anxiety Disorder-7 (GAD-7). Scores range from 0 (least severe) to 21 (most severe).

  24. Depression at 6 months

    Time frame: At 6 months after enrollment

    As measured by the Patient Health Questionnaire-9. Scores range from 0 (not at all) to 27 (nearly every day).

  25. Employment at 6 months

    Time frame: At 6 months after enrollment

    As measured by the OACIS Employment Questionnaire.

Sponsors and collaborators

Lead sponsor

Vanderbilt University Medical Center

Other

Collaborators

  • Patient-Centered Outcomes Research Institute

Registry information

Official study title

The Tube Size Randomized Trial During Emergency Tracheal Intubation

Acronym: BREATHE

Important dates

Study start
2025
Primary completion
2029
Study completion
2029
First posted
Apr 22, 2025
Registry last updated
Dec 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.